{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T03:36:10Z","timestamp":1791171370950,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1124\/mol.105.015149","type":"journal-article","created":{"date-parts":[[2005,9,8]],"date-time":"2005-09-08T20:43:45Z","timestamp":1126212225000},"page":"1736-1746","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Antihypertensive 1,4-Dihydropyridines as Correctors of the Cystic Fibrosis Transmembrane Conductance Regulator Channel Gating Defect Caused by Cystic Fibrosis Mutations"],"prefix":"10.1016","volume":"68","author":[{"given":"Nicoletta","family":"Pedemonte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tullia","family":"Diena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Caci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Nieddu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Mazzei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Ravazzolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Zegarra-Moran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis J.V.","family":"Galietta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/mol.105.015149_bib1","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S0022-3565(24)38766-X","article-title":"A common mechanism for cystic fibrosis transmembrane conductance regulator protein activation by genistein and benzimidazolone analogs","volume":"296","author":"Al-Nakkash","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/mol.105.015149_bib2","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00232-003-2020-1","article-title":"Effects of the enantiomers of BayK 8644 on the charge movement of L-type Ca channels in guinea-pig ventricular myocytes","volume":"193","author":"Artigas","year":"2003","journal-title":"J Membr Biol"},{"key":"10.1124\/mol.105.015149_bib3","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/S0026-895X(24)12096-2","article-title":"Characterization of the dexniguldipine binding site in the multidrug resistance-related transport protein P-glycoprotein by photoaffinity labeling and mass spectrometry","volume":"61","author":"Borchers","year":"2002","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.105.015149_bib4","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1023\/A:1020655724911","article-title":"The tyrosine kinase inhibitor genistein increases basal cAMP and potentiates forskolin-induced cAMP accumulation in A549 human airway epithelial cells","volume":"240","author":"Burvall","year":"2002","journal-title":"Mol Cell Biochem"},{"key":"10.1124\/mol.105.015149_bib5","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/354526a0","article-title":"Altered chloride ion channel kinetics associated with the \u0394F508 cystic fibrosis mutation","volume":"354","author":"Dalemans","year":"1991","journal-title":"Nature (Lond)"},{"key":"10.1124\/mol.105.015149_bib6","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/358761a0","article-title":"Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive","volume":"358","author":"Denning","year":"1992","journal-title":"Nature (Lond)"},{"key":"10.1124\/mol.105.015149_bib7","doi-asserted-by":"crossref","first-page":"C1657","DOI":"10.1152\/ajpcell.2001.281.5.C1657","article-title":"Activation of G551D CFTR channel with MPB-91: regulation by ATPase activity and phosphorylation","volume":"281","author":"Derand","year":"2001","journal-title":"Am J Physiol"},{"key":"10.1124\/mol.105.015149_bib8","doi-asserted-by":"crossref","first-page":"C461","DOI":"10.1152\/ajpcell.2000.279.2.C461","article-title":"Pharmacological modulation of ion transport across wild-type and DeltaF508 CFTR-expressing human bronchial epithelia","volume":"279","author":"Devor","year":"2000","journal-title":"Am J Physiol"},{"key":"10.1124\/mol.105.015149_bib9","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/chir.530020408","article-title":"Stereoselective inhibition of thromboxane-induced coronary vasoconstriction by 1,4-dihydropyridine calcium channel antagonists","volume":"2","author":"Eltze","year":"1990","journal-title":"Chirality"},{"key":"10.1124\/mol.105.015149_bib10","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/0006-291X(92)92404-L","article-title":"P-glycoprotein possesses a 1,4-dihydropyridine-selective drug acceptor site which is allosterically coupled to a vinca-alkaloid-selective binding site","volume":"188","author":"Ferry","year":"1992","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/mol.105.015149_bib11","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0014-2999(85)90631-4","article-title":"The optical isomers of the 1,4-dihydropyridine BAY K 8644 show opposite effects on Ca channels","volume":"114","author":"Franckowiak","year":"1985","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/mol.105.015149_bib12","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0014-5793(01)02561-3","article-title":"Green fluorescent protein-based halide indicators with improved chloride and iodide affinities","volume":"499","author":"Galietta","year":"2001","journal-title":"FEBS Lett"},{"key":"10.1124\/mol.105.015149_bib13","doi-asserted-by":"crossref","first-page":"C1734","DOI":"10.1152\/ajpcell.2001.281.5.C1734","article-title":"Cell-based assay for high-throughput quantitative screening of CFTR chloride transport agonists","volume":"281","author":"Galietta","year":"2001","journal-title":"Am J Physiol"},{"key":"10.1124\/mol.105.015149_bib14","first-page":"L917","article-title":"An electrogenic amino acid transporter in the apical membrane of cultured human bronchial epithelial cells","volume":"275","author":"Galietta","year":"1998","journal-title":"Am J Physiol"},{"key":"10.1124\/mol.105.015149_bib15","first-page":"3886","article-title":"Maturation and function of cystic fibrosis transmembrane conductance regulator variants bearing mutations in putative nucleotide-binding domains 1 and 2","volume":"11","author":"Gregory","year":"1991","journal-title":"Mol Cell Biol"},{"key":"10.1124\/mol.105.015149_bib16","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0014-2999(96)00465-7","article-title":"Stereoselectivity of Ca2+ channel block by dihydropyridines: no modulation by the voltage protocol","volume":"309","author":"Handrock","year":"1996","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/mol.105.015149_bib17","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1469-7793.1999.00031.x","article-title":"Dihydropyridine enantiomers block recombinant L-type Ca2+ channels by two different mechanisms","volume":"521","author":"Handrock","year":"1999","journal-title":"J Physiol"},{"key":"10.1124\/mol.105.015149_bib18","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0006-2952(02)01488-0","article-title":"Dihydropyridines as inhibitors of capacitative calcium entry in leukemic HL-60 cells","volume":"65","author":"Harper","year":"2003","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/mol.105.015149_bib19","series-title":"Foye\u2019s Principles of Medicinal Chemistry","first-page":"551","article-title":"Angiotensin converting enzyme inhibitors, antagonists and calcium blockers","author":"Harrold","year":"2002"},{"key":"10.1124\/mol.105.015149_bib20","doi-asserted-by":"crossref","first-page":"C1544","DOI":"10.1152\/ajpcell.1996.270.5.C1544","article-title":"\u0394F508-CFTR channels: kinetics, activation by forskolin and potentiation by xanthines","volume":"270","author":"Haws","year":"1996","journal-title":"Am J Physiol"},{"key":"10.1124\/mol.105.015149_bib21","doi-asserted-by":"crossref","first-page":"14906","DOI":"10.1073\/pnas.94.26.14906","article-title":"Construction of a high-affinity receptor site for dihydropyridine agonists and antagonists by single amino acid substitutions in a non-L-type Ca2+ channel","volume":"94","author":"Hockerman","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.105.015149_bib22","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1016\/0006-2952(92)90149-D","article-title":"Stereoisomers of calcium antagonists which differ markedly in their potencies as calcium blockers are equally effective in modulating drug transport by P-glycoprotein","volume":"43","author":"Hollt","year":"1992","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/mol.105.015149_bib23","doi-asserted-by":"crossref","first-page":"C988","DOI":"10.1152\/ajpcell.1997.273.3.C988","article-title":"Genistein potentiates wild-type and \u0394F508-CFTR channel activity","volume":"273","author":"Hwang","year":"1997","journal-title":"Am J Physiol"},{"key":"10.1124\/mol.105.015149_bib24","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/346362a0","article-title":"Structural model of ATP-binding proteins associated with cystic fibrosis, multidrug resistance and bacterial transport","volume":"346","author":"Hyde","year":"1990","journal-title":"Nature (Lond)"},{"key":"10.1124\/mol.105.015149_bib25","doi-asserted-by":"crossref","first-page":"C833","DOI":"10.1152\/ajpcell.1999.277.4.C833","article-title":"Defective function of the cystic fibrosis-causing mutation missense mutation G551D is recovered by genistein","volume":"277","author":"Illek","year":"1999","journal-title":"Am J Physiol"},{"key":"10.1124\/mol.105.015149_bib26","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1172\/JCI117311","article-title":"Cystic fibrosis transmembrane conductance regulator mutations that disrupt nucleotide binding","volume":"94","author":"Logan","year":"1994","journal-title":"J Clin Investig"},{"key":"10.1124\/mol.105.015149_bib27","doi-asserted-by":"crossref","first-page":"6076","DOI":"10.1002\/j.1460-2075.1994.tb06954.x","article-title":"Conformational maturation of CFTR but not its mutant counterpart (delta F508) occurs in the endoplasmic reticulum and requires ATP","volume":"13","author":"Lukacs","year":"1994","journal-title":"EMBO (Eur Mol Biol Organ) J"},{"key":"10.1124\/mol.105.015149_bib28","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1172\/JCI0216112","article-title":"Thiazolidinone CFTR inhibitor identified by high-throughput screening blocks cholera-toxin induced intestinal fluid secretion","volume":"110","author":"Ma","year":"2002","journal-title":"J Clin Investig"},{"key":"10.1124\/mol.105.015149_bib29","doi-asserted-by":"crossref","first-page":"37235","DOI":"10.1074\/jbc.M205932200","article-title":"High-affinity activators of cystic fibrosis transmembrane conductance regulator (CFTR) chloride conductance identified by high-throughput screening","volume":"277","author":"Ma","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.105.015149_bib30","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/BF00169736","article-title":"Opposite cardiac actions of the enantiomers of Bay K 8644 at different membrane potentials in guinea-pig papillary muscles","volume":"341","author":"Ravens","year":"1990","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"10.1124\/mol.105.015149_bib31","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1152\/physrev.1999.79.1.S23","article-title":"Structure and function of the CFTR chloride channel","volume":"79","author":"Sheppard","year":"1999","journal-title":"Physiol Rev"},{"key":"10.1124\/mol.105.015149_bib32","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S0165-6147(98)01171-7","article-title":"Structural basis of drug binding to L Ca2+ channels","volume":"19","author":"Striessnig","year":"1998","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/mol.105.015149_bib33","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0928-0987(02)00082-9","article-title":"Effects of 12 Ca2+ antagonists on multidrug resistance, MDR1-mediated transport and MDR1 mRNA expression","volume":"16","author":"Takara","year":"2000","journal-title":"Eur J Pharm Sci"},{"key":"10.1124\/mol.105.015149_bib34","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1161\/01.RES.56.1.87","article-title":"A dihydropyridine (Bay k 8644) that enhances calcium currents in guinea pig and calf myocardial cells. A new type of positive inotropic agent","volume":"56","author":"Thomas","year":"1985","journal-title":"Circ Res"},{"key":"10.1124\/mol.105.015149_bib35","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1085\/jgp.111.3.477","article-title":"Actions of genistein on cystic fibrosis transmembrane conductance regulator channel gating. Evidence for two binding sites with opposite effects","volume":"111","author":"Wang","year":"1998","journal-title":"J Gen Physiol"},{"key":"10.1124\/mol.105.015149_bib36","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/0092-8674(93)90353-R","article-title":"Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis","volume":"73","author":"Welsh","year":"1993","journal-title":"Cell"},{"key":"10.1124\/mol.105.015149_bib37","doi-asserted-by":"crossref","first-page":"35079","DOI":"10.1074\/jbc.M303098200","article-title":"Nanomolar affinity small molecule correctors of defective \u0394F508-CFTR chloride channel gating","volume":"278","author":"Yang","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.105.015149_bib38","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/sj.bjp.0704882","article-title":"Correction of G551D-CFTR transport defect in epithelial monolayers by genistein but not by CPX or MPB-07","volume":"137","author":"Zegarra-Moran","year":"2002","journal-title":"Br J Pharmacol"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24065714?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24065714?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.105.015149","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T04:00:54Z","timestamp":1740024054000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24065714"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["S0026895X24065714"],"URL":"https:\/\/doi.org\/10.1124\/mol.105.015149","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1030591.358702","asserted-by":"object"}]},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antihypertensive 1,4-Dihydropyridines as Correctors of the Cystic Fibrosis Transmembrane Conductance Regulator Channel Gating Defect Caused by Cystic Fibrosis Mutations","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.105.015149","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2005 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}